Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-768
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

The Long Non-Coding RNA MYCNOS-01 Regulates MYCN Protein Levels and Affects Growth of MYCN-amplified Rhabdomyosarcoma and Neuroblastoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells

Toxins
MutagenesisToxicologyHealth
2018English

The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

FAK and S6K1 Inhibitor, Neferine, Dually Induces Autophagy and Apoptosis in Human Neuroblastoma Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Inhibition of Cathepsin Proteases Attenuates Migration and Sensitizes Aggressive N-Myc Amplified Human Neuroblastoma Cells to Doxorubicin

Oncotarget
Oncology
2015English

EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy